Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutathione S-transferase pi (GSTP1) is a phase II metabolic enzyme that plays a crucial role in cellular detoxification by catalyzing the conjugation of reduced glutathione to various hydrophobic and electrophilic compounds. It is involved in protecting cells from damage caused by environmental toxins, carcinogens, and products of oxidative stress. GSTP1 also modulates cell signaling pathways and is implicated in cancer development and drug resistance, making it a potential therapeutic target and biomarker.
Inhibition of GSTP1 activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutathione S-transferase pi (GSTP1).